$REPL
Replimune Group, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Woburn, MA
REPL chart
What traders are saying about $REPL
Latest postsReplimune Group, Inc. news
- Replimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line
Stocktwits ·
- Director Joseph Slattery Sells 5,200 Shares of Replimune Group Inc (REPL)
GuruFocus ·
- Form 144 REPLIMUNE GROUP For: 9 November By Investing.com
Investing.com Canada ·
- A director proposes selling 5,200 Replimune (REPL) shares through Morgan Stanley Smith Barney.
Stock Titan ·
- Replimune Backfills Insider Trading Plans as TUDRIQEV Rollout and a Shrinking Deficit Take Center St
ad-hoc-news.de ·
- Replimune Group Inc (7R8.DU) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Technical Reactions to REPL Trends in Macro Strategies
Stock Traders Daily ·
- Three executive trading plans added by Replimune (REPL) include 488,119 shares for its chair.
Stock Titan ·
- Replimune Group, Inc. (REPL) Seasonal returns chart
Yahoo Finance UK ·
- Replimune Group stock hits 52-week high at 21.27 USD By Investing.com
Investing.com Nigeria ·
- What Just Happened With Replimune Group (REPL)?
Simply Wall St ·
- How Investors May Respond To Replimune Group (REPL) Narrower Quarterly Loss
Yahoo Finance ·
Replimune Group, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$313.9M | -$247.3M | -$215.8M | -$174.3M |
| Diluted EPS | $-3.38 | $-3.07 | $-3.24 | $-2.99 |
| Total assets (year end) | $333.6M | $603.6M | $532.9M | $678.5M |
| Cash and equivalents (year end) | $123.0M | $172.2M | $97.7M | $206.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 10-Q/AFORM 10-Q/A
- 10-Q10-Q
- 8-KFORM 8-K
- 8-KFORM 8-K
- 10-Q10-Q
- 8-KFORM 8-K
- 8-K/AFORM 8-K/A
- 8-KFORM 8-K
- 8-KFORM 8-K
- 8-KFORM 8-K
- 8-KFORM 8-K
- DEF 14AFORM -DEF 14A
About Replimune Group, Inc.
- Ticker
- REPL (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Woburn, MA
- Incorporated in
- DE
- Fiscal year end
- March 31
- SEC CIK
- 1737953
Frequently asked questions
What exchange is Replimune Group, Inc. listed on?
Replimune Group, Inc. trades on the Nasdaq under the ticker symbol REPL.
What industry is Replimune Group, Inc. in?
Replimune Group, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Replimune Group, Inc. headquartered?
Replimune Group, Inc.'s business address on file with the SEC is in Woburn, MA.
When does Replimune Group, Inc.'s fiscal year end?
Replimune Group, Inc.'s fiscal year ends on March 31.